Midterm Outcome of Laparoscopic Sleeve Gastrectomy in Asians: a Systematic Review and Meta-analysis.


Journal

Obesity surgery
ISSN: 1708-0428
Titre abrégé: Obes Surg
Pays: United States
ID NLM: 9106714

Informations de publication

Date de publication:
Apr 2020
Historique:
pubmed: 23 12 2019
medline: 15 4 2021
entrez: 23 12 2019
Statut: ppublish

Résumé

Laparoscopic sleeve gastrectomy (LSG) is a commonly performed bariatric surgery. Studies have suggested that LSG can provide effective and sustainable weight loss although most of them were conducted in Western populations. Our aim was to characterize the midterm outcome of LSG in Asians with obesity. MEDLINE and EMBASE were searched through August 2019 for studies that reported % total body weight loss (TBWL) and/or % excess weight loss (EWL) at 3 and/or 5 years among adult Asians with obesity who underwent LSG. Data on complications and surgical revision rate were also extracted. The pooled effect size and 95% confidence interval (CI) were calculated using a random effects model. A total of 19 studies involving 6235 patients were included. The pooled mean %EWLs were 72.6% (95% CI 67.2-78.0, I Our meta-analysis suggests that LSG is an effective procedure for weight reduction that offers durable response for up to 5 years among Asians with obesity. The longer-term data is needed.

Sections du résumé

BACKGROUND BACKGROUND
Laparoscopic sleeve gastrectomy (LSG) is a commonly performed bariatric surgery. Studies have suggested that LSG can provide effective and sustainable weight loss although most of them were conducted in Western populations. Our aim was to characterize the midterm outcome of LSG in Asians with obesity.
METHODS METHODS
MEDLINE and EMBASE were searched through August 2019 for studies that reported % total body weight loss (TBWL) and/or % excess weight loss (EWL) at 3 and/or 5 years among adult Asians with obesity who underwent LSG. Data on complications and surgical revision rate were also extracted. The pooled effect size and 95% confidence interval (CI) were calculated using a random effects model.
RESULTS RESULTS
A total of 19 studies involving 6235 patients were included. The pooled mean %EWLs were 72.6% (95% CI 67.2-78.0, I
CONCLUSIONS CONCLUSIONS
Our meta-analysis suggests that LSG is an effective procedure for weight reduction that offers durable response for up to 5 years among Asians with obesity. The longer-term data is needed.

Identifiants

pubmed: 31865553
doi: 10.1007/s11695-019-04332-2
pii: 10.1007/s11695-019-04332-2
doi:

Types de publication

Journal Article Meta-Analysis Systematic Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

1459-1467

Références

Obes Surg. 2014 Oct;24(10):1724-8
pubmed: 24805912
Surg Endosc. 2017 Nov;31(11):4331-4345
pubmed: 28378086
J Gastrointest Surg. 2019 Mar;23(3):445-450
pubmed: 30187324
Int J Surg. 2017 Dec;48:201-209
pubmed: 29122706
Gastroenterology. 2007 May;132(6):2253-71
pubmed: 17498516
Obes Surg. 2010 Mar;20(3):357-62
pubmed: 20013071
Int J Obes Relat Metab Disord. 2003 Feb;27(2):253-9
pubmed: 12587007
Surg Obes Relat Dis. 2018 Mar;14(3):259-263
pubmed: 29370995
Obes Surg. 2013 Sep;23(9):1497-500
pubmed: 23820896
Obes Surg. 2019 May;29(5):1462-1469
pubmed: 30666544
Diabetes Care. 2011 Feb;34(2):353-7
pubmed: 21216863
Obes Surg. 2012 Mar;22(3):507-14
pubmed: 22246395
Oncotarget. 2016 Nov 15;7(46):76308-76315
pubmed: 27729621
Yonsei Med J. 2017 Sep;58(5):1025-1030
pubmed: 28792149
BMC Surg. 2015 Jul 22;15:88
pubmed: 26198306
Surg Obes Relat Dis. 2012 May-Jun;8(3):e21-6
pubmed: 22417852
Surg Obes Relat Dis. 2018 Jun;14(6):741-747
pubmed: 29625744
Obes Surg. 2013 Jul;23(7):939-46
pubmed: 23462857
Diabetes Obes Metab. 2018 Jul;20(7):1762-1765
pubmed: 29460379
Obes Surg. 2014 Oct;24(10):1617-24
pubmed: 24827405
Obes Surg. 2008 Sep;18(9):1083-8
pubmed: 18535864
Obes Surg. 2016 Jan;26(1):138-45
pubmed: 25986429
Surg Obes Relat Dis. 2016 Aug;12(7):1305-1311
pubmed: 27297975
Obes Res. 2001 Jul;9(7):381-7
pubmed: 11445659
Obes Surg. 2015 May;25(5):800-4
pubmed: 25428511
Asian J Surg. 2018 May;41(3):285-290
pubmed: 28689733
Obes Surg. 2013 Dec;23(12):2096-103
pubmed: 23868139
Obes Surg. 2015 Oct;25(10):1901-8
pubmed: 25761944
Obes Surg. 2012 May;22(5):721-31
pubmed: 22411568
J Surg Res. 2019 Apr;236:345-351
pubmed: 30694776
Obes Surg. 2018 Oct;28(10):2991-2997
pubmed: 29931481
Obes Surg. 2015 May;25(5):824-9
pubmed: 25381478
Ann Surg Treat Res. 2015 May;88(5):246-52
pubmed: 25960987
Asian J Surg. 2016 Jan;39(1):21-8
pubmed: 25964106
BMJ. 2003 Sep 6;327(7414):557-60
pubmed: 12958120

Auteurs

Veeravich Jaruvongvanich (V)

Department of Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA.

Nicha Wongjarupong (N)

Department of Internal Medicine, University of Minnesota, Minneapolis, MN, USA. nwongjarupong@gmail.com.

Kornpong Vantanasiri (K)

Department of Internal Medicine, University of Minnesota, Minneapolis, MN, USA.

Parinya Samakkarnthai (P)

Division of Endocrinology, Department of Medicine, Phramongkutklao Hospital, Bangkok, Thailand.

Patompong Ungprasert (P)

Division of Clinical Epidemiology, Department of Research and Development, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH